Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/1999
12/16/1999WO1999064401A2 Imidazolyl derivatives and their use as somatostatin receptor ligands
12/16/1999WO1999064400A1 INHIBITORS OF p38
12/16/1999WO1999064399A1 Protease inhibitors
12/16/1999WO1999064060A1 Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein
12/16/1999WO1999064043A1 Muscarinic receptor antagonists
12/16/1999WO1999064039A1 Bradykinin antagonists
12/16/1999WO1999064029A1 Plant extract
12/16/1999WO1999064021A1 hCEPR RECEPTOR
12/16/1999WO1999064020A1 Use of ozone for the preparation of medicaments for the treatment of dental caries
12/16/1999WO1999064017A1 Method and system for production and collection of lavage induced stool (lis) for chemical and biologic tests of cells
12/16/1999WO1999064016A1 Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
12/16/1999WO1999064004A1 QUINAZOLINONE INHIBITORS OF cGMP PHOSPHODIESTERASE
12/16/1999WO1999054280B1 Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation
12/16/1999WO1999041375A3 Human receptor proteins
12/16/1999WO1998024902A8 Adaptor protein frs2 and related products and methods
12/16/1999DE19825804A1 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung 1,4-benzothiazepine 1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use
12/16/1999CA2335339A1 .beta.-carboline compounds
12/16/1999CA2334970A1 Quinazolinone inhibitors of cgmp phosphodiesterase
12/16/1999CA2334945A1 Imidazolyl derivatives
12/16/1999CA2334798A1 1,5-benzodiazepine derivatives
12/16/1999CA2334652A1 Protease inhibitors
12/16/1999CA2334431A1 Use of ozone for the preparation of medicaments for the treatment of dental caries
12/16/1999CA2333691A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors
12/16/1999CA2333629A1 Furopyridine derivatives and their therapeutical use
12/16/1999CA2330251A1 Cloning and identification of the motilin receptor
12/16/1999CA2330211A1 Formulations for electroporation
12/16/1999CA2319730A1 Bradykinin antagonists
12/16/1999CA2315883A1 Muscarinic receptor antagonists
12/15/1999EP0963983A1 Indol-2-ones as serotonin modulators
12/15/1999EP0963200A2 Methods and compositions for inhibition of angiogenesis
12/15/1999EP0765305B1 Anti-inflammatory compounds
12/15/1999EP0725782B1 A 1 adenosine receptor agonists and antiagonists
12/15/1999EP0642504B1 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
12/15/1999CN1238771A 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
12/15/1999CN1238755A Asiatic acid derivatives having modified A-ring
12/15/1999CN1238211A Yexiazhu tablet for treating hepatism
12/14/1999US6002009 Di-substituted 1,4-piperidine esters and amides having 5-HT4 antagonistic activity
12/14/1999US6001990 Antisense inhibition of hepatitis C virus
12/14/1999US6001973 Antagonists of interleukin-15
12/14/1999US6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor
12/14/1999US6001880 Disubstituted n-(2-dialkylaminoethyl)benzamide derivatives of given formula; antibacterial activity against helicobacter pyroli, administering for the prevention or cure of peptic ulcers
12/14/1999US6001833 Novel piperazine derivatives which are substituted in the 2-position by an indolylmethyl radical and in which the nitrogen in the 4-position of the piperazine ring forms part of a urea structure bearing a benzylaminoethyl substituent
12/14/1999US6001832 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
12/14/1999US6001830 Heterocyclic compounds
12/14/1999US6001823 Novel pyranosides which are believed to be capable of interacting with periplasmic molecular chaperones
12/14/1999US6001802 Antiproliferative agents
12/14/1999US6001799 Method of treating hepatitis C in non-responders to interferon treatment
12/14/1999US6001651 Antisense modulation of LFA-3
12/14/1999US6001623 Polynucleotide sequence coding a human enzymatic polypeptide; for developing treatments and diagnostic assays for disease
12/14/1999US6001603 Polynucleotide sequence coding for a staphylococcus enzmatic protein; for diagnosis, treatment and prevention of bacterial infections; bactericides
12/14/1999US6001358 Useful for treatment of autoimmune diseases
12/14/1999CA2181150C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
12/14/1999CA2135487C Heteroaromatic quinuclidinenes, their use and preparation
12/14/1999CA2014971C Inhibitive agent against activity of alpha-amylase
12/09/1999WO1999062883A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
12/09/1999WO1999062875A1 Nitric oxide synthase inhibitors
12/09/1999WO1999062534A1 IL-6/sIL-6R COMPLEX FOR PROMOTION OF LIVER FUNCTIONS
12/09/1999WO1999062518A1 PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE
12/09/1999WO1999062507A1 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
12/09/1999WO1999062498A1 Spill resistant pharmaceutical compositions
12/09/1999WO1999006397A3 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists
12/09/1999CA2329512A1 Il-6/sil-6r complex for promotion of liver functions
12/08/1999EP0962457A1 Piperidones as tachykinin antagonists
12/08/1999EP0961775A2 Purine l-nucleosides, analogs and uses thereof
12/08/1999EP0961618A1 Novel compounds
12/08/1999EP0784620B1 N-substituted piperidinyl bicyclic benzoate derivatives
12/08/1999CN1237962A Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
12/08/1999CN1237908A Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
12/08/1999CN1237894A Dentifrice compositions containing polyphosphate and fluoride
12/08/1999CN1237446A Yatong Yicijing medicine for curing toothache
12/08/1999CN1047171C Method for preparing 1,2-dithiol-3-thion-S-oxid-compound pharmaceutical
12/08/1999CN1047075C Bisacodyl dosage form
12/07/1999US5998666 Phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same
12/07/1999US5998487 Anti-inflammatory and antibacterial benzyl phenol agents and their use in oral compositions
12/07/1999US5998470 Osteoporosis; oral diseases; antiarthritic agents
12/07/1999US5998469 Nervous system diosrders; autoimmune diseases; antiinflammatory agents
12/07/1999US5998445 Peptic ulcers
12/07/1999US5998429 Azabicyclic esters of carbamic acids useful in therapy
12/07/1999US5998390 Combination of bisphosphonate and tetracycline
12/07/1999CA2162248C Liquid antacid compositions
12/07/1999CA2161886C Heteroatom substituted alkylbenzylaminoquinuclidines
12/02/1999WO1999061918A1 Method and means for caries prevention and susceptibility detection
12/02/1999WO1999061916A1 Identification of broadly reactive dr restricted epitopes
12/02/1999WO1999061621A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4
12/02/1999WO1999061611A1 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
12/02/1999WO1999061471A2 Human transmembrane proteins
12/02/1999WO1999061440A1 Novel substituted imidazole compounds
12/02/1999WO1999061439A1 Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria
12/02/1999WO1999061437A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999WO1999061427A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999WO1999061426A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999WO1999061421A1 A NOVEL VLA-4 INHIBITOR: oMePUPA-V
12/02/1999WO1999061031A1 Treatment of c. difficile toxin b associated conditions
12/02/1999WO1999060984A2 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
12/02/1999WO1999052548A3 Conjugate vaccines for the prevention of dental caries
12/02/1999WO1999050413A3 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
12/02/1999WO1999019354A9 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
12/02/1999CA2333537A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999CA2333157A1 Novel substituted imidazole compounds
12/02/1999CA2332932A1 Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria
1 ... 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 ... 1258